Business
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION
About this update from Iradimed Corporation
[{"type":"text","content":"Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance\nORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible medical devices, today announced its selection to TIME's prestigious list of America's Growth Leaders for 2026. This marks the Company's recognition among the top U.S. companies demonstrating outstanding growth, as determined by TIME and Statista. The ranking evaluated thousands of public companies across three key dimensions: Revenue Growth, Financial, and Stock Performance. Scores from these dimensions were weighted equally in a comprehensive model, with the highest-scoring 501 companies earning the distinction of \"America's Growth Leaders of 2026.” Iradimed ranked 79th on the list. “We are honored to be named to TIME's America's Growth Leaders for 2026,” said Roger Susi, President and Chief Executive Officer of Iradimed. “This recognition reflects our team's relentless commitment to innovation, operational excellence, and delivering long-term shareholder return. Our consistent revenue growth—highlighted by 17 consecutive quarters of record revenue—along with strong financial health and stock performance, underscores the success of our strategy in the MRI-compatible medical device market. We extend our deepest gratitude to our employees for their hard work and dedication, and to our shareholders for their continued support.” For more information and the complete list, visit: https://time.com/7327022/americas-growth-leaders-2025/. About the Methodology TIME and Statista evaluated U.S.-based public companies using a rigorous, data-driven approach across three equally weighted dimensions: Revenue Growth: Focused on compound annual growth rate (CAGR) from 2021 to 2024, with a minimum revenue threshold.Financial Stability: Analyzed profitability alongside classic metrics such as the Piotroski F-Score and Altman Z-Score.Stock Performance: Assessed using multiple KPIs, including average annual growth rate, recent returns, comparison to the overall market, and volatility over the past five years. Data was consolidated into a scoring model with a maximum of 100 points. The 501 companies with the highest scores were named America's Growth Leaders of 2026. About IRADIMED CORPORATION IRADIME...